VYTORIN and ZETIA are currently indicated for use along with a healthy diet to reduce elevated LDL cholesterol in patients with hyperlipidemia. The current U.S. Prescribing Information for both ...
The study was a randomized, placebo-controlled comparison of the effects of daily treatment with fenofibrate 160 mg, ezetimibe-simvastatin 10/20 mg, ezetimibe-simvastatin 10/20 mg plus fenofibrate 160 ...
PARIS, FRANCE AND TARRYTOWN, NY — Another drug that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) appears to have cleared a hurdle today, with Sanofi and Regeneron reporting top-line ...
A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback